Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin

FEBS Journal

Volumn 279, Issue 17, 2012, Pages 3166-3175

  Luo, Xiao ^a   Jiang, Qian ^a   Song, Ge ^a   Liu, Ya Li ^b   Xu, Zeng Guang ^b   Guo, Zhan Yun ^a  

^a TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ferroportin; hepcidin; oxidative folding; reversible S modification; site specific labeling

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FERROPORTIN; HEPCIDIN; PROPARGYLGLYCINE; RED FLUORESCENT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; CHEMICAL LABELING; CLICK CHEMISTRY; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; HUMAN; HUMAN CELL; INTERNALIZATION; OXIDATIVE FOLDING; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN REFOLDING; SITE SPECIFIC LABELING;

AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCYTOSIS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN FOLDING;

EID: 84865209549     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08695.x     Document Type: Article

References (35)

1. Hentze MW, Muckenthaler MU, Galy B, &, Camaschella C, (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38.
2. Nemeth E, &, Ganz T, (2009) The role of hepcidin in iron metabolism. Acta Haematol 122, 78-86.
3. Viatte L, &, Vaulont S, (2009) Hepcidin, the iron watcher. Biochimie 91, 1223-1228.
4. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, &, Adermann K, (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147-150.
5. Park CH, Valore EV, Waring AJ, &, Ganz T, (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806-7810.
6. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, &, Loréal O, (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811-7819.
7. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, &, Vaulont S, (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98, 8780-8785.
8. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Sawadogo M, Kahn A, &, Vaulont S, (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99, 4596-4601.
9. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, &, Camaschella C, (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33, 21-22.
10. Yeh KY, Yeh M, &, Glass J, (2004) Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat. Am J Physiol Gastrointest Liver Physiol 286, G385-G394.
11. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, &, Kaplan J, (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
12. De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, &, Kaplan J, (2007) The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 18, 2569-2578.
13. De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, &, Kaplan J, (2008) The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 8, 146-156.
14. Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T, &, Craik DJ, (2011) Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chem Biol 18, 336-343.
15. Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, Sharma S, Waring A, Ganz T, &, Nemeth E, (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 121, 4880-4888.
16. Fernandes A, Preza GC, Phung Y, De Domenico I, Kaplan J, Ganz T, &, Nemeth E, (2009) The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114, 437-443.
17. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, et al. (2009) Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 284, 24155-24167.
18. Zhang J, Diamond S, Arvedson T, Sasu BJ, &, Miranda LP, (2010) Oxidative folding of hepcidin at acidic pH. Biopolymers 94, 257-264.
19. Zhang H, Yuan Q, Zhu Y, &, Ma R, (2005) Expression and preparation of recombinant hepcidin in Escherichia coli. Protein Expr Purif 41, 409-416.
20. Gagliardo B, Faye A, Jaouen M, Deschemin JC, Canonne-Hergaux F, Vaulont S, &, Sari MA, (2008) Production of biologically active forms of recombinant hepcidin, the iron-regulatory hormone. FEBS J 275, 3793-3803.
21. Koliaraki V, Marinou M, Samiotaki M, Panayotou G, Pantopoulos K, &, Mamalaki A, (2008) Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastoris. Biochimie 90, 726-735.
22. Chan WW, (1968) A method for the complete S sulfonation of cysteine residues in proteins. Biochemistry 7, 4247-4254.
23. Cowley DJ, &, Mackin RB, (1997) Expression, purification and characterization of recombinant human proinsulin. FEBS Lett 402, 124-130.
24. Lange C, &, Rudolph R, (2009) Suppression of protein aggregation by L-arginine. Curr Pharm Biotechnol 10, 408-414.
25. Nakakido M, Kudou M, Arakawa T, &, Tsumoto K, (2009) To be excluded or to bind, that is the question: arginine effects on proteins. Curr Pharm Biotechnol 10, 415-420.
26. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, &, Ganz T, (2006) The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107, 328-333.
27. Khemtemourian L, Desbenoit N, Mahesh P, Chatterjee S, Deschemin JC, Vaulont S, Tomas A, Sari MA, &, Artaud I, (2012) Synthesis and biological activity of mouse hepcidin peptide analogs containing three disulfide bridges: manual and microwave-assisted solid-phase peptide synthesis. Protein Pept Lett 19, 219-227.
28. Bulaj G, &, Olivera BM, (2008) Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides. Antioxid Redox Signal 10, 141-155.
29. Craik DJ, Mylne JS, &, Daly NL, (2010) Cyclotides: macrocyclic peptides with applications in drug design and agriculture. Cell Mol Life Sci 67, 9-16.
30. Sosnick TR, Berry RS, Colubri A, &, Fernández A, (2002) Distinguishing foldable proteins from nonfolders: when and how do they differ? Proteins 49, 15-23.
31. Dobson CM, (2006) Protein aggregation and its consequences for human disease. Protein Pept Lett 13, 219-227.
32. Darlak K, Wiegandt Long D, Czerwinski A, Darlak M, Valenzuela F, Spatola AF, &, Barany G, (2004) Facile preparation of disulfide-bridged peptides using the polymer-supported oxidant CLEAR-OX. J Pept Res 63, 303-312.
33. Best MD, (2009) Click chemistry and bioorthogonal reactions: unprecedented selectivity in the labeling of biological molecules. Biochemistry 48, 6571-6584.
34. Kolb HC, Finn MG, &, Sharpless KB, (2001) Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 40, 2004-2021.
35. Ross SL, Tran L, Winters A, Lee KJ, Plewa C, Foltz I, King C, Miranda LP, Allen J, Beckman H, et al. (2012) Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab 15, 905-917.